Evidence map›Paper›PMID 31988300›Full record

ArticleScientific reports2020

A Clinically Relevant Functional Model of Type-2 Cardio-Renal Syndrome with Paraventricular Changes consequent to Chronic Ischaemic Heart Failure.

Joanne Clare Harrison, Scott Duncan George Smart, Emma Maria Hinemoa Besley, Jessica Renee Kelly, Morgayn Iona Read, Yimin Yao, Ivan Andrew Sammut

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Joanne Clare HarrisonDepartment of Pharmacology and Toxicology, School of BioMedical Sciences, University of Otago Medical School, Dunedin, New Zealand. joanne.harrison@otago.ac.nz.
Scott Duncan George SmartDepartment of Pharmacology and Toxicology, School of BioMedical Sciences, University of Otago Medical School, Dunedin, New Zealand.
Emma Maria Hinemoa BesleyDepartment of Pharmacology and Toxicology, School of BioMedical Sciences, University of Otago Medical School, Dunedin, New Zealand.
Jessica Renee KellyDepartment of Pharmacology and Toxicology, School of BioMedical Sciences, University of Otago Medical School, Dunedin, New Zealand.
Morgayn Iona ReadDepartment of Pharmacology and Toxicology, School of BioMedical Sciences, University of Otago Medical School, Dunedin, New Zealand.
Yimin YaoDepartment of Pharmacology and Toxicology, School of BioMedical Sciences, University of Otago Medical School, Dunedin, New Zealand.
Ivan Andrew SammutDepartment of Pharmacology and Toxicology, School of BioMedical Sciences, University of Otago Medical School, Dunedin, New Zealand.
University of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiorenal syndrome, de novo renal pathology arising secondary to cardiac insufficiency, is clinically recognised but poorly characterised. This study establishes and characterises a valid model representative of Type 2 cardiorenal syndrome. Extensive permanent left ventricular infarction, induced by ligation of the left anterior descending coronary artery in Lewis rats, was confirmed by plasma cardiac troponin I, histology and cardiac haemodynamics. Renal function and morphology was assessed 90-days post-ligation when heart failure had developed. The involvement of the paraventricular nucleus was investigated using markers of inflammation, apoptosis, reactive oxygen species and of angiotensin II involvement. An extensive left ventricular infarct was confirmed following coronary artery ligation, resulting in increased left ventricular weight and compromised left ventricular diastolic function and developed pressure. Glomerular filtration was significantly decreased, fractional excretion of sodium and caspase activities were increased and basement membrane thickening, indicating glomerulosclerosis, was evident. Interestingly, angiotensin II receptor I expression and reactive oxygen species levels in the hypothalamic paraventricular nucleus remained significantly increased at 90-days post-coronary artery ligation, suggesting that these hypothalamic changes may represent a novel, valuable pharmacological target. This model provides conclusive morphological, biochemical and functional evidence of renal injury consequent to heart failure, truly representative of Type-2 cardiorenal syndrome.

Indexed as

AnimalsCardio-Renal SyndromeDisease Models, AnimalGlomerular Filtration RateHeart VentriclesHemodynamicsKidneyMaleMyocardial InfarctionMyocardial IschemiaOxidative StressParaventricular Hypothalamic NucleusRatsRats, Inbred LewTroponin IVentricular Dysfunction, LeftTroponin I

Identifiers

PMID31988300
PMCPMC6985167
OpenAlexW3001686517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.